These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 10523467

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Troglitazone in type II diabetes mellitus.
    Sparano N, Seaton TL.
    Pharmacotherapy; 1998; 18(3):539-48. PubMed ID: 9620105
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Type 2 diabetes: glycemic targets and oral therapies for older patients.
    Lardinois CK.
    Geriatrics; 1998 Nov; 53(11):22-3, 27-8, 33-4 passim. PubMed ID: 9824974
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes.
    Caro JJ, Klittich WS, Raggio G, Kavanagh PL, O'Brien JA, Shomphe LA, Flegel KM, Copley-Merriman C, Sigler C.
    Clin Ther; 2000 Jan; 22(1):116-27. PubMed ID: 10688395
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Utilization of oral hypoglycemic agents in a drug-insured U.S. population.
    Boccuzzi SJ, Wogen J, Fox J, Sung JC, Shah AB, Kim J.
    Diabetes Care; 2001 Aug; 24(8):1411-5. PubMed ID: 11473078
    [Abstract] [Full Text] [Related]

  • 34. [Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea].
    Ohmura E, Hosaka D, Imai Y, Kawazu S.
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():470-5. PubMed ID: 12387036
    [No Abstract] [Full Text] [Related]

  • 35. Troglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Plosker GL, Faulds D.
    Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691
    [Abstract] [Full Text] [Related]

  • 36. [Drug treatment of type 2 diabetes].
    Tielmans A, Laloi-Michelin M, Coupaye M, Virally M, Meas T, Guillausseau PJ.
    Presse Med; 2007 Feb; 36(2 Pt 2):269-78. PubMed ID: 17258675
    [Abstract] [Full Text] [Related]

  • 37. New treatments for patients with type 2 diabetes mellitus.
    Wolffenbuttel BH, Graal MB.
    Postgrad Med J; 1996 Nov; 72(853):657-62. PubMed ID: 8944206
    [Abstract] [Full Text] [Related]

  • 38. Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone.
    Iwamoto Y, Kosaka K, Kuzuya T, Akanuma Y, Shigeta Y, Kaneko T.
    Diabet Med; 1996 Apr; 13(4):365-70. PubMed ID: 9162613
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. On combination therapy of diabetes with metformin and dipeptidyl peptidase IV inhibitors.
    Hinke SA, McIntosh CH, Hoffmann T, Kühn-Wache K, Wagner L, Bär J, Manhart S, Wermann M, Pederson RA, Demuth HU.
    Diabetes Care; 2002 Aug; 25(8):1490-1; author reply 1491-2. PubMed ID: 12145269
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.